Barbora Peltanová

658 total citations
8 papers, 446 citations indexed

About

Barbora Peltanová is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Barbora Peltanová has authored 8 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Barbora Peltanová's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Barbora Peltanová is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Barbora Peltanová collaborates with scholars based in Czechia, Netherlands and Germany. Barbora Peltanová's co-authors include Martina Raudenská, Michal Masařík, Hana Polanská, Jiří Navrátil, Jaroslav Juráček, Jaromír Gumulec, Jan Betka, David Kalfeřt, Michal Fedorko and Jan Doležel and has published in prestigious journals such as Scientific Reports, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Barbora Peltanová

7 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbora Peltanová Czechia 6 228 197 157 113 70 8 446
Huangming Hong China 10 212 0.9× 237 1.2× 165 1.1× 97 0.9× 63 0.9× 51 554
Yanjie You China 15 307 1.3× 196 1.0× 144 0.9× 65 0.6× 80 1.1× 46 527
Yujie Liang China 11 199 0.9× 197 1.0× 116 0.7× 203 1.8× 42 0.6× 19 474
Katheryn Begg United Kingdom 4 281 1.2× 163 0.8× 164 1.0× 60 0.5× 82 1.2× 7 505
Irene Arroyo‐Solera Spain 10 238 1.0× 121 0.6× 121 0.8× 81 0.7× 82 1.2× 11 391
Emily Pittman United States 9 205 0.9× 285 1.4× 96 0.6× 99 0.9× 126 1.8× 22 508
Huda I. Atiya United States 8 175 0.8× 258 1.3× 114 0.7× 202 1.8× 61 0.9× 11 491
Justin Wang United States 9 206 0.9× 144 0.7× 87 0.6× 122 1.1× 45 0.6× 12 430
Yasuyuki Maruse Japan 9 123 0.5× 206 1.0× 85 0.5× 131 1.2× 60 0.9× 16 392
Insoon Chang United States 8 392 1.7× 236 1.2× 155 1.0× 63 0.6× 37 0.5× 12 526

Countries citing papers authored by Barbora Peltanová

Since Specialization
Citations

This map shows the geographic impact of Barbora Peltanová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbora Peltanová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbora Peltanová more than expected).

Fields of papers citing papers by Barbora Peltanová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbora Peltanová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbora Peltanová. The network helps show where Barbora Peltanová may publish in the future.

Co-authorship network of co-authors of Barbora Peltanová

This figure shows the co-authorship network connecting the top 25 collaborators of Barbora Peltanová. A scholar is included among the top collaborators of Barbora Peltanová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbora Peltanová. Barbora Peltanová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Peltanová, Barbora, et al.. (2026). Migrastatic therapy as a potential game-changer in adaptive cancer treatment. Scientific Reports. 16(1). 3929–3929.
2.
Navrátil, Jiří, et al.. (2022). Metabolic tricks of cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1877(3). 188705–188705. 54 indexed citations
3.
Peltanová, Barbora, Hana Polanská, Martina Raudenská, et al.. (2022). mRNA Subtype of Cancer-Associated Fibroblasts Significantly Affects Key Characteristics of Head and Neck Cancer Cells. Cancers. 14(9). 2286–2286. 8 indexed citations
4.
Raudenská, Martina, et al.. (2022). Metabolic plasticity of cancer cells. Klinicka onkologie. 35(3). 195–207. 2 indexed citations
5.
Fojtů, Michaela, Jan Balvan, Tomáš Vičar, et al.. (2021). Silicane Derivative Increases Doxorubicin Efficacy in an Ovarian Carcinoma Mouse Model: Fighting Drug Resistance. ACS Applied Materials & Interfaces. 13(27). 31355–31370. 9 indexed citations
6.
Peltanová, Barbora, Jaromír Gumulec, Martina Raudenská, et al.. (2021). Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. 22(4). 1912–1912. 23 indexed citations
7.
Peltanová, Barbora, Martina Raudenská, & Michal Masařík. (2019). Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Molecular Cancer. 18(1). 63–63. 316 indexed citations
8.
Juráček, Jaroslav, Barbora Peltanová, Jan Doležel, et al.. (2018). Genome‐wide identification of urinary cell‐free microRNAs for non‐invasive detection of bladder cancer. Journal of Cellular and Molecular Medicine. 22(3). 2033–2038. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026